Home > Research > Publications & Outputs > Incorporating demand and supply constraints int...

Research

Links

Text available via DOI:

View graph of relations

Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries. / Vassall, Anna; Mangham-Jefferies, Lindsay; Gomez, Gabriela B et al.
In: Health Economics, Vol. 25, No. Supp 1, 01.02.2016, p. 95-115.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Vassall, A, Mangham-Jefferies, L, Gomez, GB, Pitt, C & Foster, N 2016, 'Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries', Health Economics, vol. 25, no. Supp 1, pp. 95-115. https://doi.org/10.1002/hec.3306

APA

Vassall, A., Mangham-Jefferies, L., Gomez, G. B., Pitt, C., & Foster, N. (2016). Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries. Health Economics, 25(Supp 1), 95-115. https://doi.org/10.1002/hec.3306

Vancouver

Vassall A, Mangham-Jefferies L, Gomez GB, Pitt C, Foster N. Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries. Health Economics. 2016 Feb 1;25(Supp 1):95-115. doi: 10.1002/hec.3306

Author

Vassall, Anna ; Mangham-Jefferies, Lindsay ; Gomez, Gabriela B et al. / Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries. In: Health Economics. 2016 ; Vol. 25, No. Supp 1. pp. 95-115.

Bibtex

@article{7fa59c7265b74a799f8c178295ebcb43,
title = "Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries",
abstract = "Global guidelines for new technologies are based on cost and efficacy data from a limited number of trial locations. Country‐level decision makers need to consider whether cost‐effectiveness analysis used to inform global guidelines are sufficient for their situation or whether to use models that adjust cost‐effectiveness results taking into account setting‐specific epidemiological and cost heterogeneity. However, demand and supply constraints will also impact cost‐effectiveness by influencing the standard of care and the use and implementation of any new technology. These constraints may also vary substantially by setting. We present two case studies of economic evaluations of the introduction of new diagnostics for malaria and tuberculosis control. These case studies are used to analyse how the scope of economic evaluations of each technology expanded to account for and then address demand and supply constraints over time. We use these case studies to inform a conceptual framework that can be used to explore the characteristics of intervention complexity and the influence of demand and supply constraints. Finally, we describe a number of feasible steps that researchers who wish to apply our framework in cost‐effectiveness analyses.",
author = "Anna Vassall and Lindsay Mangham-Jefferies and Gomez, {Gabriela B} and Catherine Pitt and Nicola Foster",
year = "2016",
month = feb,
day = "1",
doi = "10.1002/hec.3306",
language = "English",
volume = "25",
pages = "95--115",
journal = "Health Economics",
issn = "1057-9230",
publisher = "John Wiley and Sons Ltd",
number = "Supp 1",

}

RIS

TY - JOUR

T1 - Incorporating demand and supply constraints into economic evaluations in low-income and middle-income countries

AU - Vassall, Anna

AU - Mangham-Jefferies, Lindsay

AU - Gomez, Gabriela B

AU - Pitt, Catherine

AU - Foster, Nicola

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Global guidelines for new technologies are based on cost and efficacy data from a limited number of trial locations. Country‐level decision makers need to consider whether cost‐effectiveness analysis used to inform global guidelines are sufficient for their situation or whether to use models that adjust cost‐effectiveness results taking into account setting‐specific epidemiological and cost heterogeneity. However, demand and supply constraints will also impact cost‐effectiveness by influencing the standard of care and the use and implementation of any new technology. These constraints may also vary substantially by setting. We present two case studies of economic evaluations of the introduction of new diagnostics for malaria and tuberculosis control. These case studies are used to analyse how the scope of economic evaluations of each technology expanded to account for and then address demand and supply constraints over time. We use these case studies to inform a conceptual framework that can be used to explore the characteristics of intervention complexity and the influence of demand and supply constraints. Finally, we describe a number of feasible steps that researchers who wish to apply our framework in cost‐effectiveness analyses.

AB - Global guidelines for new technologies are based on cost and efficacy data from a limited number of trial locations. Country‐level decision makers need to consider whether cost‐effectiveness analysis used to inform global guidelines are sufficient for their situation or whether to use models that adjust cost‐effectiveness results taking into account setting‐specific epidemiological and cost heterogeneity. However, demand and supply constraints will also impact cost‐effectiveness by influencing the standard of care and the use and implementation of any new technology. These constraints may also vary substantially by setting. We present two case studies of economic evaluations of the introduction of new diagnostics for malaria and tuberculosis control. These case studies are used to analyse how the scope of economic evaluations of each technology expanded to account for and then address demand and supply constraints over time. We use these case studies to inform a conceptual framework that can be used to explore the characteristics of intervention complexity and the influence of demand and supply constraints. Finally, we describe a number of feasible steps that researchers who wish to apply our framework in cost‐effectiveness analyses.

U2 - 10.1002/hec.3306

DO - 10.1002/hec.3306

M3 - Journal article

VL - 25

SP - 95

EP - 115

JO - Health Economics

JF - Health Economics

SN - 1057-9230

IS - Supp 1

ER -